Jennison Associates LLC Amneal Pharmaceuticals, Inc. Transaction History
Jennison Associates LLC
- $141 Billion
- Q1 2025
A detailed history of Jennison Associates LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 71,426 shares of AMRX stock, worth $600,692. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,426Holding current value
$600,692% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
245Shares Held
136MCall Options Held
302KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA15.8MShares$133 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$104 Million3.16% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$94.9 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$90.3 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$63 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.27B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...